The reported statements, read against the company's own industry.
What stands out
Valued far above the size of its business
Financials view
Market Capitalization
6.08BCNY
907.54M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
334.83x
vs Health Information Services peers
Updated Sep 22, 2026
Revenue (TTM)
289.44MCNY
43.22M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
6.03%
vs Health Information Services peers
Updated Sep 22, 2026
Beta
0.5260x
vs all stocks
Updated Sep 22, 2026
52-Week Change
41.01%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
6.08BCNY
907.54M · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
5.87BCNY
876.89M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
334.83x
vs Health Information Services peers
Updated Sep 22, 2026
Forward P/E
17.78x
vs Health Information Services peers
Updated Sep 22, 2026
Price to Sales (TTM)
21.19x
vs Health Information Services peers
Updated Sep 22, 2026
Price to Book (MRQ)
7.20x
vs Health Information Services peers
Updated Sep 22, 2026
Enterprise to Revenue
20.29x
vs Health Information Services peers
Updated Sep 22, 2026
Gross Margin
58.07%
vs Health Information Services peers
Updated Sep 22, 2026
Profit Margin
6.03%
vs Health Information Services peers
Updated Sep 22, 2026
Operating Margin
5.89%
vs Health Information Services peers
Updated Sep 22, 2026
Return on Assets (TTM)
0.69%
vs Health Information Services peers
Updated Sep 22, 2026
Return on Equity (TTM)
2.27%
vs Health Information Services peers
Updated Sep 22, 2026
Revenue (TTM)
289.44MCNY
43.22M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
0.9350CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
-14.50%
vs Health Information Services peers
Updated Sep 22, 2026
Gross Profit (TTM)
169.99MCNY
25.38M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
22.41MCNY
3.35M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
17.46MCNY
2.61M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
-41.10%
vs Health Information Services peers
Updated Sep 22, 2026
Operating Cash Flow (TTM)
69.83MCNY
10.43M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
318.14MCNY
47.51M · vs all stocks (USD)
Updated Sep 22, 2026
5-Year Average Dividend Yield
0.41%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Sep 22, 2026
Minority Interest (Equity)
10.49MCNYFY2025 · Dec 31, 2025
Revenue
301.48MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
119.28MCNYFY2025 · Dec 31, 2025
Gross Profit
182.20MCNYFY2025 · Dec 31, 2025
Operating Income
22.61MCNY
3.38M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
45.40MCNYFY2025 · Dec 31, 2025
Income Tax Expense
3.91MCNYFY2025 · Dec 31, 2025
Net Income
41.49MCNYFY2025 · Dec 31, 2025
EBIT
58.29MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
83.83MCNYFY2025 · Dec 31, 2025
Research & Development
28.60MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
46.57MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.26MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
8.26MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
12.89MCNYFY2025 · Dec 31, 2025
Net Income from Continuing Operations
41.49MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-2.33MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
98.81MCNYFY2025 · Dec 31, 2025
Free Cash Flow
31.63MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
277.84MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
41.49MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
14.15MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
33.54MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
9.64MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-67.19MCNYFY2025 · Dec 31, 2025
Net Acquisitions
274.04MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-525.20MCNYFY2025 · Dec 31, 2025
Sale of Investments
565.97MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
247.62MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
222.19MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-382.70MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-10.22MCNYFY2025 · Dec 31, 2025
Other Financing Charges
35.76MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-134.97MCNYFY2025 · Dec 31, 2025
Shares Outstanding
305.25MSharesUpdated Sep 22, 2026
Float Shares
233.02MSharesUpdated Sep 22, 2026
% Held by Insiders
27.68%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
0.46%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
489.54MCNY
73.10M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
1.62CNYUpdated Sep 22, 2026
Total Debt (MRQ)
229.42MCNY
34.26M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.2688x
vs Health Information Services peers
Updated Sep 22, 2026
Current Ratio (MRQ)
2.37x
vs Health Information Services peers
Updated Sep 22, 2026
Book Value per Share (MRQ)
2.79CNYUpdated Sep 22, 2026
Total Assets
1.24BCNY
185.55M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
797.30MCNYFY2025 · Dec 31, 2025
Total Liabilities
397.15MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
445.27MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
54.12MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
343.03MCNYFY2025 · Dec 31, 2025
Cash
277.62MCNYFY2025 · Dec 31, 2025
Cash Equivalents
16.35MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
293.97MCNYFY2025 · Dec 31, 2025
Accounts Receivable
175.76MCNYFY2025 · Dec 31, 2025
Inventory
31.43MCNYFY2025 · Dec 31, 2025
Accounts Payable
43.56MCNYFY2025 · Dec 31, 2025
Short-term Debt
220.13MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.63MCNYFY2025 · Dec 31, 2025
Long-term Debt
54.12MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
306.28MCNYFY2025 · Dec 31, 2025
Retained Earnings
-199.67MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
845.41MCNY
126.25M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
61.37MCNYFY2025 · Dec 31, 2025
52-Week Low
13.74CNYUpdated Sep 22, 2026
52-Week High
25.03CNYUpdated Sep 22, 2026
52-Week Change
41.01%
vs all stocks
Updated Sep 22, 2026
Beta
0.5260x
vs all stocks
Updated Sep 22, 2026
50-Day MA
20.49CNYUpdated Sep 22, 2026
200-Day MA
17.62CNYUpdated Sep 22, 2026
Avg 10-Day Volume
11.53MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
19.59MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
0.0600CNYUpdated Sep 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 334.83×, higher than 95% of its Health Information Services peers (median 34.15×)Significant